Matheron S - Search Results

1

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.

Benard A, van Sighem A, Taieb A, Valadas E, Ruelle J, Soriano V, Calmy A, Balotta C, Damond F, Brun-Vezinet F, Chene G, Matheron S; ACHIEV2E Collaboration Study Group. Benard A, et al. Among authors: matheron s. Clin Infect Dis. 2011 May;52(10):1257-66. doi: 10.1093/cid/cir123. Clin Infect Dis. 2011. PMID: 21507923 Free article.

2

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.

Meynard JL, Vray M, Morand-Joubert L, Race E, Descamps D, Peytavin G, Matheron S, Lamotte C, Guiramand S, Costagliola D, Brun-Vézinet F, Clavel F, Girard PM; Narval Trial Group. Meynard JL, et al. Among authors: matheron s. AIDS. 2002 Mar 29;16(5):727-36. doi: 10.1097/00002030-200203290-00008. AIDS. 2002. PMID: 11964529 Clinical Trial.

3

Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections.

Damond F, Gueudin M, Pueyo S, Farfara I, Robertson DL, Descamps D, Chène G, Matheron S, Campa P, Brun-Vézinet F, Simon F. Damond F, et al. Among authors: matheron s. J Clin Microbiol. 2002 Oct;40(10):3654-9. doi: 10.1128/JCM.40.10.3654-3659.2002. J Clin Microbiol. 2002. PMID: 12354861 Free PMC article.

4

Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.

Calvez V, Costagliola D, Descamps D, Yvon A, Collin G, Cécile A, Delaugerre C, Damond F, Marcelin AG, Matheron S, Simon A, Valantin MA, Katlama C, Brun-Vézinet F. Calvez V, et al. Among authors: matheron s. Antivir Ther. 2002 Sep;7(3):211-8. Antivir Ther. 2002. PMID: 12487389

5

Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial.

Matheron S, Descamps D, Boué F, Livrozet JM, Lafeuillade A, Aquilina C, Troisvallets D, Goetschel A, Brun-Vezinet F, Mamet JP, Thiaux C; CNA3007 Study Group. Matheron S, et al. Antivir Ther. 2003 Apr;8(2):163-71. Antivir Ther. 2003. PMID: 12741629 Clinical Trial.

6

Clinical and immunologic outcome in patients with human immunodeficiency virus infection, according to virologic efficacy in the year after virus undetectability, during antiretroviral therapy.

Abgrall S, Duval X, Joly V, Descamps D, Matheron S, Costagliola D; Clinical Epidemiology Group from the French Hospital Database on HIV. Abgrall S, et al. Among authors: matheron s. Clin Infect Dis. 2003 Dec 1;37(11):1517-26. doi: 10.1086/379070. Epub 2003 Oct 29. Clin Infect Dis. 2003. PMID: 14614675

7

Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort.

Matheron S, Pueyo S, Damond F, Simon F, Leprêtre A, Campa P, Salamon R, Chêne G, Brun-Vezinet F; French HIV-2 Cohort Study Group. Matheron S, et al. AIDS. 2003 Dec 5;17(18):2593-601. doi: 10.1097/00002030-200312050-00006. AIDS. 2003. PMID: 14685053

8

Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification.

Damond F, Worobey M, Campa P, Farfara I, Colin G, Matheron S, Brun-Vézinet F, Robertson DL, Simon F. Damond F, et al. Among authors: matheron s. AIDS Res Hum Retroviruses. 2004 Jun;20(6):666-72. doi: 10.1089/0889222041217392. AIDS Res Hum Retroviruses. 2004. PMID: 15242544

9

High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen.

Descamps D, Damond F, Matheron S, Collin G, Campa P, Delarue S, Pueyo S, Chêne G, Brun-Vézinet F; French ANRS HIV-2 Cohort Study Group. Descamps D, et al. Among authors: matheron s. J Med Virol. 2004 Oct;74(2):197-201. doi: 10.1002/jmv.20174. J Med Virol. 2004. PMID: 15332266

10

Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen.

Damond F, Matheron S, Peytavin G, Campa P, Taieb A, Collin G, Delaunay C, Chêne G, Brun-Vézinet F, Descamps D. Damond F, et al. Among authors: matheron s. Antivir Ther. 2004 Aug;9(4):635-6. Antivir Ther. 2004. PMID: 15456096 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters